A/DT
Primer/NN
for/IN
Disease/NN
Gene/NN
Prioritization/NN
Using/VBG
Next-Generation/JJ
Sequencing/NN
Data/NNS
./.
====================
High-throughput/JJ
next-generation/NN
sequencing/NN
(/(
NGS/NN
)/)
technology/NN
produces/VBZ
a/DT
tremendous/JJ
amount/NN
of/IN
raw/NN
sequence/NN
data/NNS
./.
====================
The/DT
challenges/NNS
for/IN
researchers/NNS
are/VBP
to/TO
process/NN
the/DT
raw/NN
data/NNS
,/,
to/TO
map/VB
the/DT
sequences/NNS
to/TO
genome/NN
,/,
to/TO
discover/RB
variants/NNS
that/IN
are/VBP
different/JJ
from/IN
the/DT
reference/NN
genome/NN
,/,
and/CC
to/TO
prioritize/rank/VB
the/DT
variants/NNS
for/IN
the/DT
question/NN
of/IN
interest/NN
./.
====================
The/DT
recent/JJ
development/NN
of/IN
many/JJ
computational/JJ
algorithms/NNS
and/CC
programs/NNS
has/VBZ
vastly/RB
improved/JJ
the/DT
ability/NN
to/TO
translate/VB
sequence/NN
data/NNS
into/IN
valuable/JJ
information/NN
for/IN
disease/NN
gene/NN
identification/NN
./.
====================
However/RB
,/,
the/DT
NGS/NN
data/NNS
analysis/NN
is/VBZ
complex/JJ
and/CC
could/MD
be/VB
overwhelming/VBG
for/IN
researchers/NNS
who/WP
are/VBP
not/RB
familiar/JJ
with/IN
the/DT
process/NN
./.
====================
Here/RB
,/,
we/PRP
outline/VBP
the/DT
analysis/NN
pipeline/NN
and/CC
describe/VBP
some/DT
of/IN
the/DT
most/JJS
commonly/RB
used/VBN
principles/NNS
and/CC
tools/NNS
for/IN
analyzing/VBG
NGS/NN
data/NNS
for/IN
disease/NN
gene/NN
identification/NN
./.
====================
The/DT
breakthrough/JJ
in/IN
next-generation/JJ
sequencing/NN
(/(
NGS/NN
)/)
techniques/NNS
has/VBZ
enabled/VBN
rapid/JJ
sequencing/NN
of/IN
whole/JJ
genomes/NNS
at/IN
low/JJ
cost/JJ
and/CC
has/VBZ
brought/VBN
tremendous/JJ
opportunities/NNS
as/IN
well/RB
as/IN
challenges/NNS
to/TO
biomedical/JJ
research/NN
[/(
1-5/CD
]/)
./.
====================
The/DT
cost/JJ
of/IN
sequencing/NN
is/VBZ
projected/VBN
to/TO
continue/VB
to/TO
drop/VB
,/,
with/IN
whole-genome/DT
sequencing/NN
expected/VBN
to/TO
be/VB
as/IN
low/JJ
as/IN
$/RB
1000/CD
[/(
4/CD
]/)
and/CC
whole-exome/JJ
sequencing/NN
(/(
i.e./FW
,/,
sequencing/VBG
approximately/RB
1/CD
%/NN
of/IN
the/DT
coding/VBG
regions/NNS
of/IN
the/DT
genome/NN
[/(
6/CD
]/)
)/)
to/TO
be/VB
$/CD
500/CD
[/(
1/CD
]/)
./.
====================
Such/JJ
low/JJ
costs/NNS
enable/VBP
a/DT
small/JJ
research/NN
lab/NN
to/TO
generate/VB
large/JJ
amounts/NNS
of/IN
sequence/NN
data/NNS
in/IN
a/DT
short/JJ
period/NN
of/IN
time/NN
on/IN
a/DT
relatively/RB
small/JJ
budget/NN
./.
====================
The/DT
low/JJ
cost/JJ
also/RB
allows/VBZ
sequencing-based/VBN
clinical/JJ
genetic/JJ
tests/NNS
to/TO
be/VB
routinely/RB
performed/VBN
to/TO
provide/VB
guidance/NN
for/IN
health/NN
professionals/NNS
for/IN
disease/NN
etiology/NN
and/CC
management/JJ
./.
====================
The/DT
challenge/NN
now/RB
is/VBZ
how/WRB
to/TO
reliably/RB
synthesize/VB
and/CC
interpret/JJ
this/DT
large/JJ
amount/NN
of/IN
raw/NN
data/NNS
from/IN
sequencing/NN
platforms/NNS
./.
====================
One/CD
goal/NN
of/IN
genomic/JJ
research/NN
is/VBZ
to/TO
determine/VB
which/WDT
genes/NNS
are/VBP
causal/JJ
for/IN
the/DT
disease/NN
of/IN
interest/NN
./.
====================
With/IN
the/DT
NGS/NN
data/NNS
,/,
this/DT
is/VBZ
not/RB
a/DT
trivial/JJ
task/NN
./.
====================
Large-scale/JJ
whole-genome/WP$
and/CC
whole-exome/JJ
sequencing/NN
analyses/NNS
identify/VBP
large/JJ
amounts/NNS
of/IN
genomic/JJ
variants/NNS
,/,
most/JJS
of/IN
which/WDT
are/VBP
not/RB
related/JJ
to/TO
disease/NN
risk/NN
./.
====================
Thus/RB
,/,
disease/NN
gene/NN
prioritization/NN
principles/NNS
and/CC
tools/NNS
are/VBP
needed/VBN
[/(
2/CD
]/)
to/TO
identify/VB
and/CC
prioritize/VBP
variants/NNS
of/IN
interest/NN
from/IN
the/DT
large/JJ
pool/NN
of/IN
candidates/NNS
./.
====================
Currently/RB
,/,
identifying/VBG
candidate/NN
causal/JJ
mutations/genes/NNS
is/VBZ
often/RB
a/DT
complex/NN
practice/NN
that/DT
involves/VBZ
several/JJ
dozens/NNS
of/IN
steps/NNS
and/or/CC
tools/NNS
to/TO
accomplish/VB
./.
====================
These/DT
tools/NNS
work/NN
jointly/RB
in/IN
a/DT
series/NN
of/IN
steps/NNS
and/CC
thus/RB
functionally/RB
form/VBP
a/DT
``/JJ
workflow/NN
''/CD
or/CC
a/DT
``/JJ
pipeline/NN
./.
''/CD
====================
Ideally/RB
,/,
the/DT
process/NN
of/IN
disease/NN
gene/NN
prioritization/NN
generates/VBZ
an/DT
ordered/VBN
list/NN
of/IN
genes/NNS
that/WDT
puts/VBZ
high-risk/VBP
candidates/NNS
on/IN
the/DT
top/NN
of/IN
the/DT
stack/NN
and/CC
filters/NNS
out/IN
``/CD
benign/JJ
''/NN
or/CC
neutral/JJ
variants/NNS
./.
====================
In/IN
reality/NN
,/,
this/DT
process/NN
usually/RB
involves/VBZ
multiple/JJ
filtering/VBG
steps/NNS
,/,
some/DT
of/IN
which/WDT
have/VBP
underlying/VBG
assumptions/NNS
that/DT
can/MD
affect/VB
how/WRB
variants/NNS
are/VBP
filtered/VBN
./.
====================
The/DT
focus/NN
of/IN
this/DT
review/NN
is/VBZ
to/TO
provide/VB
a/DT
broad/JJ
overview/NN
of/IN
the/DT
workflow/NN
and/CC
present/JJ
some/DT
of/IN
the/DT
bioinformatics/NNS
software/JJ
tools/NNS
that/DT
are/VBP
currently/RB
available/JJ
./.
====================
More/RBR
in-depth/IN
comparisons/NNS
of/IN
the/DT
bioinformatics/NNS
algorithms/NNS
and/CC
tools/NNS
are/VBP
described/VBN
elsewhere/RB
[/(
3/CD
,/,
5/CD
]/)
./.
====================
Typically/RB
,/,
the/DT
output/NN
from/IN
NGS/NN
platforms/NNS
is/VBZ
in/IN
the/DT
standard/JJ
FASTQ/NN
format/IN
./.
====================
The/DT
FASTQ/NN
file/JJ
is/VBZ
a/DT
text/JJ
file/JJ
containing/VBG
a/DT
list/NN
of/IN
short/JJ
DNA/NN
fragments/NNS
,/,
generally/RB
less/RBR
than/IN
150/CD
base/NN
pairs/NNS
(/(
bp/NN
)/)
long/JJ
,/,
and/CC
a/DT
list/NN
of/IN
quality/NN
scores/VBZ
associated/VBN
with/IN
the/DT
DNA/NN
fragments/NNS
./.
====================
For/IN
whole-genome/DT
or/CC
whole-exome/JJ
sequencing/NN
,/,
a/DT
FASTQ/NN
file/JJ
contains/VBZ
millions/NNS
of/IN
records/NNS
./.
====================
For/IN
example/NN
,/,
the/DT
human/JJ
exome/JJ
is/VBZ
~50/CD
million/NN
base/NN
pairs/NNS
(/(
Mbp/JJ
)/)
,/,
and/CC
a/DT
typical/JJ
whole-exome/JJ
sequencing/NN
dataset/NN
has/VBZ
at/IN
least/JJS
30X/CD
depth/NN
of/IN
coverage/JJ
(/(
i.e./FW
,/,
each/DT
bp/NN
is/VBZ
sequenced/VBN
30/CD
times/NNS
on/IN
average/NN
)/)
./.
====================
Such/JJ
a/DT
FASTQ/NN
file/JJ
will/MD
contain/VB
~15/CD
million/NN
raw/NN
100-bp/JJ
sequences/NNS
./.
====================
To/TO
identify/VB
the/DT
causal/JJ
genes/NNS
from/IN
this/DT
raw/NN
data/NNS
,/,
a/DT
variant/JJ
gene/NN
prioritization/NN
pipeline/NN
usually/RB
involves/VBZ
three/CD
stages/NNS
or/CC
phases/NNS
of/IN
data/NNS
processing/NN
:/:
1/CD
)/)
raw/VBP
sequence/NN
processing/NN
and/CC
mapping/VBG
,/,
2/CD
)/)
variant/JJ
discovery/NN
and/CC
genotyping/VBG
,/,
and/CC
3/CD
)/)
disease/NN
gene/NN
filtering/VBG
and/or/CC
prioritization/NN
./.
====================
Phase/NN
1/CD
:/:
Raw/NN
sequence/NN
processing/NN
and/CC
mapping/NN
====================
Overview/NN
====================
The/DT
goal/NN
of/IN
Phase/NN
1/CD
is/VBZ
to/TO
preprocess/VB
the/DT
FASTQ/NN
file/JJ
and/CC
evaluate/VBP
the/DT
quality/NN
of/IN
the/DT
raw/JJ
reads/VBZ
and/CC
then/RB
to/TO
map/VB
or/CC
align/RB
the/DT
sequences/NNS
to/TO
the/DT
reference/NN
genome-that/IN
is/VBZ
,/,
to/TO
find/VB
the/DT
best/JJS
location/NN
on/IN
the/DT
reference/NN
genome/NN
where/WRB
each/DT
sequence/NN
might/MD
have/VBP
originated/VBN
./.
====================
Successfully/RB
mapped/VBD
sequences/NNS
are/VBP
annotated/VBN
with/IN
information/NN
that/IN
includes/VBZ
the/DT
location/NN
on/IN
a/DT
specific/JJ
chromosome/NN
and/CC
how/WRB
well/RB
the/DT
sequence/NN
matches/NNS
the/DT
reference/NN
genome/NN
./.
====================
After/IN
initial/JJ
mapping/NN
,/,
there/EX
are/VBP
several/JJ
subsequent/JJ
recalibration/NN
steps/NNS
to/TO
improve/VB
the/DT
mapping/NN
results/VBZ
./.
====================
Preprocessing/VBG
====================
The/DT
raw/NN
FASTQ/NN
file/JJ
contains/VBZ
all/DT
of/IN
the/DT
raw/NN
sequences/NNS
,/,
some/DT
of/IN
which/WDT
are/VBP
of/IN
low/JJ
quality/NN
./.
====================
The/DT
overall/JJ
quality/NN
should/MD
be/VB
evaluated/VBN
,/,
and/CC
the/DT
lower-quality/JJ
reads/VBZ
should/MD
be/VB
removed/VBN
before/IN
mapping/NN
to/TO
the/DT
reference/NN
genome/NN
to/TO
improve/VB
mapping/VBG
efficiency/NN
./.
====================
FASTQC/NN
(/(
http/NN
:/:
//www.bioinformatics.babraham.ac.uk/projects/fastqc//JJ
)/)
is/VBZ
a/DT
popular/JJ
tool/NN
that/DT
produces/VBZ
quality/NN
analysis/NN
reports/NNS
on/IN
FASTQ/NN
files/NNS
./.
====================
FASTQC/NN
provides/VBZ
graphical/JJ
reports/NNS
on/IN
several/JJ
useful/JJ
statistics/NNS
,/,
such/JJ
as/IN
``/CD
Per/NN
base/NN
sequence/NN
quality/NN
,/,
''/NNP
``/CD
Sequence/NN
duplication/NN
levels/NNS
,/,
''/NNP
and/CC
``/NN
Overrepresented/JJ
sequences/NNS
,/,
''/NNP
etc/JJ
./.
====================
Specifically/RB
,/,
``/NNP
Per/NN
base/NN
sequence/NN
quality/NN
''/CD
determines/VBZ
if/IN
trimming/VBG
low-quality/JJ
sequences/NNS
is/VBZ
needed/VBN
before/IN
the/DT
mapping/alignment/JJ
step/NN
;/:
``/RB
Sequence/NN
duplication/NN
levels/NNS
''/RB
evaluates/VBZ
the/DT
library/NN
enrichment/JJ
and/CC
complexity/NN
;/:
and/CC
``/FW
Overrepresented/JJ
sequences/NNS
''/``
evaluates/VBZ
potential/JJ
adaptor/NN
contamination/NN
./.
====================
Low-quality/JJ
bases/NNS
and/CC
adaptor/NN
contaminations/NNS
can/MD
cause/VB
an/DT
otherwise/JJ
mappable/JJ
sequence/NN
not/RB
to/TO
map/VB
and/CC
therefore/RB
should/MD
be/VB
removed/VBN
(/(
e.g./FW
,/,
trim/NN
the/DT
3/CD
'/``
end/NN
of/IN
the/DT
read/JJ
./.
====================
which/WDT
tends/VBZ
to/TO
have/VB
low/JJ
quality/NN
)/)
./.
====================
FASTX-Toolkit/NN
(/(
http/NN
:/:
//hannonlab.cshl.edu/fastx_toolkit//JJ
)/)
provides/VBZ
a/DT
set/NN
of/IN
command/CC
line/NN
tools/NNS
for/IN
manipulating/VBG
FASTQ/NN
files/NNS
,/,
such/JJ
as/IN
trimming/VBG
input/NN
sequences/NNS
down/RB
to/TO
a/DT
fixed/JJ
length/NN
or/CC
trimming/VBG
low-quality/JJ
bases/NNS
./.
====================
Cutadapt/NN
(/(
https/NNS
:/:
//github.com/marcelm/cutadapt/JJ
)/)
can/MD
be/VB
used/VBN
for/IN
trimming/VBG
short/JJ
reads/VBZ
to/TO
remove/VB
potential/JJ
adapter/NN
contamination/NN
./.
====================
Mapping/NN
====================
Once/RB
high-quality/JJ
sequence/NN
data/NNS
are/VBP
obtained/VBN
,/,
a/DT
number/NN
of/IN
bioinformatics/NNS
programs/NNS
,/,
including/VBG
Mosaik/NNP
[/(
7/CD
]/)
,/,
MAQ/NNP
(/(
http/NN
:/:
//maq.sourceforge.net//JJ
)/)
,/,
mrFAST/NN
[/(
8/CD
]/)
,/,
BWA/NNP
[/(
9/CD
]/)
,/,
Bowtie2/NNP
[/(
10/CD
]/)
,/,
SOAP2/NN
[/(
11/CD
]/)
,/,
and/CC
Subread/JJ
[/(
12/CD
]/)
,/,
can/MD
be/VB
used/VBN
to/TO
perform/VB
short-read/JJ
sequence/NN
alignment/RB
to/TO
the/DT
reference/NN
genome/NN
./.
====================
Several/JJ
recent/JJ
studies/NNS
provided/VBD
a/DT
detailed/JJ
description/NN
and/CC
comparison/NN
of/IN
the/DT
alignment/NN
programs/NNS
[/(
5/CD
,/,
13/CD
]/)
,/,
although/IN
it/PRP
could/MD
be/VB
difficult/JJ
to/TO
choose/VB
among/IN
aligners/NNS
,/,
because/IN
benchmark/VBP
results/NNS
vary/VBP
across/IN
studies/NNS
[/(
10/CD
,/,
12/CD
,/,
14/CD
]/)
./.
====================
BWA/NN
and/CC
Bowtie2/NN
are/VBP
two/CD
popular/JJ
programs/NNS
for/IN
alignment/NN
./.
====================
Both/DT
programs/NNS
employ/VB
the/DT
Burrows-Wheeler/NN
transform/VBP
(/(
BWT/NN
)/)
algorithm/NN
and/CC
have/VBP
been/VBN
shown/VBN
to/TO
yield/VB
very/RB
good/JJ
overall/JJ
performance/NN
[/(
13/CD
]/)
./.
====================
Bowtie2/DT
is/VBZ
often/RB
used/VBN
for/IN
mapping/VBG
ChIP-seq/NN
and/CC
RNA-seq/NN
data/NNS
,/,
and/CC
BWA/NN
is/VBZ
often/RB
used/VBN
for/IN
mapping/VBG
whole-genome/exome/WP$
data/NNS
./.
====================
We/PRP
highlight/VBP
the/DT
BWA/NN
program/NN
here/RB
,/,
because/IN
it/PRP
is/VBZ
accurate/JJ
,/,
fast/JJ
,/,
thoroughly/RB
tested/VBN
,/,
and/CC
well/RB
supported/VBD
./.
====================
Additionally/RB
,/,
BWA/NNP
has/VBZ
been/VBN
utilized/VBN
in/IN
multiple/JJ
large-scale/JJ
projects/NNS
and/CC
well-defined/JJ
workflows/VBZ
,/,
including/VBG
the/DT
Genome/NN
Analysis/NN
Toolkit/NN
(/(
GATK/NN
)/)
by/IN
Broad/JJ
Institute/RB
[/(
15/CD
]/)
,/,
the/DT
1000/CD
Genome/NNP
Project/JJ
[/(
16/CD
]/)
,/,
the/DT
NHLBI/NN
GO/NN
Exome/NN
Sequencing/NN
Project/JJ
(/(
ESP/NN
)/)
(/(
http/NN
:/:
//evs.gs.washington.edu/EVS//JJ
)/)
,/,
and/CC
the/DT
HugeSeq/NNP
workflow/IN
[/(
17/CD
]/)
./.
====================
Various/JJ
commercial/JJ
companies/NNS
,/,
such/JJ
as/IN
Seven/JJ
Bridges/NNS
Genomics/NNS
(/(
https/NNS
:/:
//www.sbgenomics.com//JJ
)/)
and/CC
Geospiza/NN
GeneSifter/NN
(/(
http/NN
:/:
//www.geospiza.com//JJ
)/)
,/,
also/RB
utilize/VBP
BWA/NN
in/IN
their/PRP$
standard/JJ
workflows/VBZ
./.
====================
After/IN
mapping/NN
the/DT
reads/VBZ
,/,
the/DT
final/JJ
output/NN
file/JJ
from/IN
most/JJS
software/RB
is/VBZ
typically/RB
in/IN
the/DT
sequence/NN
alignment/map/VBP
(/(
SAM/NN
)/)
format/VBP
[/(
18/CD
]/)
./.
====================
In/IN
some/DT
cases/NNS
,/,
the/DT
SAM/NN
file/JJ
is/VBZ
converted/VBN
to/TO
its/PRP$
binary/NN
format/IN
(/(
BAM/NN
)/)
using/VBG
SAMtools/NNS
[/(
18/CD
]/)
to/TO
reduce/VB
the/DT
file/JJ
size/NN
and/CC
optimize/VBP
computation/NN
performance/NN
./.
====================
Recalibration/NN
====================
After/IN
the/DT
initial/JJ
mapping/NN
procedure/NN
,/,
subsequent/JJ
recalibration/NN
steps/NNS
are/VBP
typically/RB
employed/VBN
to/TO
improve/VB
the/DT
mapping/NN
results/VBZ
,/,
such/JJ
as/IN
performing/JJ
local/JJ
realignment/JJ
or/CC
de/FW
novo/FW
assembly/NN
for/IN
regions/NNS
that/IN
contain/VBP
insertions/deletions/NNS
(/(
indels/VBZ
)/)
,/,
removing/VBG
PCR/NN
duplicates/NNS
,/,
and/CC
recalibrating/VBG
the/DT
base/NN
quality/NN
scores/VBZ
./.
====================
Indel/NN
realignment/JJ
is/VBZ
a/DT
highly/RB
recommended/VBN
post-BAM/NN
processing/NN
procedure/NN
./.
====================
Due/IN
to/TO
the/DT
trade-off/JJ
between/IN
speed/JJ
and/CC
accuracy/NN
,/,
indels/VBZ
are/VBP
not/RB
well/RB
aligned/VBN
by/IN
most/JJS
general/JJ
purpose/NN
aligners/NNS
./.
====================
This/DT
could/MD
lead/VB
to/TO
false/VB
variant/JJ
calls/NNS
in/IN
downstream/JJ
analyses/NNS
./.
====================
Regions/NNS
with/IN
high/JJ
probability/NN
of/IN
potential/JJ
indels/VBZ
can/MD
be/VB
realigned/VBN
locally/RB
using/VBG
IndelRealigner/NN
,/,
part/NN
of/IN
the/DT
GATK/NN
toolkit/NN
./.
====================
Another/DT
commonly/RB
used/VBN
recalibration/NN
procedure/NN
is/VBZ
removing/VBG
PCR/NN
duplicates/NNS
./.
====================
If/IN
a/DT
DNA/NN
fragment/NN
is/VBZ
amplified/VBN
many/JJ
times/NNS
by/IN
PCR/NN
during/IN
the/DT
sequencing/NN
library/NN
construction/NN
,/,
these/DT
artificially/RB
duplicated/JJ
sequences/NNS
can/MD
be/VB
considered/VBN
as/IN
support/VBP
of/IN
a/DT
variant/JJ
by/IN
downstream/JJ
variant/JJ
discovery/NN
programs/NNS
./.
====================
Some/DT
BAM/NN
processing/NN
programs/NNS
,/,
such/JJ
as/IN
Picard/JJ
(/(
http/NN
:/:
//picard.sourceforge.net//JJ
)/)
and/CC
Samtools/NNS
[/(
18/CD
]/)
,/,
can/MD
identify/VB
these/DT
artificially/RB
duplicated/JJ
sequences/NNS
and/CC
remove/VBP
them/PRP
./.
====================
Base/NN
recalibration/NN
is/VBZ
also/RB
a/DT
recommended/JJ
step/NN
,/,
because/IN
the/DT
sequencer/NN
may/MD
have/VB
assigned/VBN
a/DT
biased/JJ
quality/NN
score/RB
upon/IN
reading/VBG
a/DT
base/NN
(/(
e.g./FW
,/,
the/DT
score/RB
of/IN
a/DT
second/JJ
``/NN
A/DT
''/JJ
base/NN
after/IN
a/DT
first/JJ
``/NN
A/DT
''/JJ
base/NN
may/MD
always/RB
receive/JJ
a/DT
biased/JJ
quality/NN
score/RB
from/IN
a/DT
sequence/NN
machine/NN
[/(
19/CD
]/)
)/)
./.
====================
Tools/NNS
,/,
such/JJ
as/IN
Base-Recalibrator/NN
in/IN
the/DT
GATK/NN
toolkit/NN
,/,
can/MD
calibrate/VB
the/DT
quality/NN
score/RB
to/TO
more/RBR
accurately/RB
reflect/VBP
the/DT
probability/NN
of/IN
a/DT
base/NN
mismatching/VBG
the/DT
reference/NN
genome/NN
./.
====================
One/CD
additional/JJ
optional/JJ
step/NN
,/,
recommended/VBD
by/IN
GATK/NN
,/,
is/VBZ
data/NNS
compression/NN
and/CC
reads/VBZ
reduction/NN
,/,
especially/RB
for/IN
high-coverage/JJ
data/NNS
./.
====================
For/IN
example/NN
,/,
if/IN
a/DT
large/JJ
chunk/NN
of/IN
sequences/NNS
matches/NNS
the/DT
reference/NN
exactly/RB
,/,
it/PRP
is/VBZ
not/RB
necessary/JJ
to/TO
keep/VB
all/DT
the/DT
data/NNS
,/,
as/IN
they/PRP
do/VBP
not/RB
carry/RB
useful/JJ
information/NN
for/IN
downstream/JJ
analyses/NNS
(/(
assuming/VBG
we/PRP
are/VBP
only/RB
interested/JJ
in/IN
the/DT
sites/NNS
that/IN
are/VBP
different/JJ
from/IN
the/DT
reference/NN
genome/NN
)/)
./.
====================
In/IN
such/JJ
a/DT
scenario/NN
,/,
keeping/VBG
one/CD
copy/NN
of/IN
each/DT
of/IN
the/DT
consensus/NN
sequences/NNS
may/MD
be/VB
sufficient/JJ
,/,
and/CC
the/DT
redundancies/NNS
can/MD
be/VB
removed/VBN
to/TO
reduce/VB
file/JJ
size/NN
and/CC
enable/VBP
faster/JJR
downstream/JJ
computing/VBG
./.
====================
However/RB
,/,
keeping/VBG
a/DT
copy/NN
of/IN
the/DT
original/JJ
file/JJ
is/VBZ
highly/RB
recommended/VBN
after/IN
data/NNS
compression/NN
./.
====================
Phase/NN
2/CD
:/:
Variant/JJ
discovery/NN
and/CC
genotyping/VBG
====================
Overview/NN
====================
In/IN
many/JJ
scenarios/NNS
,/,
only/RB
the/DT
sites/NNS
that/IN
differ/VBP
from/IN
the/DT
reference/NN
genome/NN
are/VBP
of/IN
interest/NN
,/,
because/IN
sites/NNS
that/IN
are/VBP
identical/JJ
to/TO
the/DT
reference/NN
genome/NN
are/VBP
not/RB
expected/VBN
to/TO
be/VB
related/JJ
to/TO
pathological/JJ
conditions/NNS
./.
====================
Once/RB
raw/NN
sequences/NNS
are/VBP
properly/RB
mapped/VBD
to/TO
the/DT
reference/NN
genome/NN
,/,
the/DT
next/JJ
step/NN
is/VBZ
to/TO
find/VB
all/DT
positions/NNS
in/IN
an/DT
individual/JJ
's/POS
genome/NN
that/IN
differed/VBD
from/IN
the/DT
reference/NN
./.
====================
This/DT
phase/NN
is/VBZ
referred/VBN
to/TO
as/IN
variant/JJ
discovery/NN
,/,
or/CC
variant/JJ
calling/JJ
./.
====================
Similar/JJ
to/TO
the/DT
mapping/VBG
phase/NN
,/,
variant/JJ
calling/JJ
also/RB
contains/VBZ
an/DT
initial/JJ
discovery/NN
step/NN
,/,
followed/VBN
by/IN
several/JJ
filtering/VBG
processes/NNS
to/TO
remove/VB
sequencing/NN
errors/NNS
and/CC
other/JJ
types/NNS
of/IN
false/JJ
discoveries/VBZ
,/,
and/CC
finally/RB
,/,
the/DT
individual/JJ
genotypes/NNS
are/VBP
inferred/VBN
(/(
i.e./FW
,/,
if/IN
a/DT
locus/NN
is/VBZ
heterozygous/JJ
,/,
homozygous/JJ
,/,
or/CC
hemizygous/JJ
for/IN
the/DT
variant/JJ
)/)
./.
====================
The/DT
output/JJ
of/IN
variant/JJ
calling/JJ
contains/VBZ
all/DT
the/DT
variants/NNS
and/CC
related/JJ
information/NN
./.
====================
Sites/NNS
that/DT
are/VBP
identical/JJ
to/TO
the/DT
reference/NN
genome/NN
(/(
i.e./FW
,/,
invariant/JJ
sites/NNS
)/)
are/VBP
usually/RB
not/RB
included/VBN
in/IN
the/DT
output/NN
variant/JJ
file/JJ
./.
====================
Variant/JJ
discovery/NN
and/CC
genotyping/VBG
====================
A/DT
number/NN
of/IN
variant/JJ
calling/JJ
software/JJ
packages/NNS
can/MD
be/VB
used/VBN
to/TO
identify/VB
variants/NNS
and/CC
call/JJ
individual/JJ
genotypes/NNS
./.
====================
Some/DT
of/IN
the/DT
commonly/RB
used/VBN
software/JJ
programs/NNS
are/VBP
SAMtools/NNS
[/(
18/CD
]/)
,/,
freebayes/NNS
(/(
http/NN
:/:
//github.com/ekg/freebayes/NNS
)/)
,/,
SNPtools/NNS
[/(
20/CD
]/)
,/,
GATK/NN
UnifiedGenotyper/JJ
,/,
and/CC
GATK/NN
HaplotypeCaller/NN
./.
====================
Some/DT
of/IN
the/DT
tools/NNS
,/,
including/VBG
SAMtools/NNS
,/,
SNPtools/NNS
,/,
and/CC
the/DT
GATK/NN
UnifiedGenotyper/JJ
,/,
use/NN
a/DT
mapping-based/VBN
approach/NN
./.
====================
Other/JJ
tools/NNS
,/,
such/JJ
as/IN
freebayes/NNS
and/CC
the/DT
GATK/NN
Haplotype-Caller/NN
,/,
use/NN
a/DT
local/JJ
assembly/NN
approach/NN
./.
====================
A/DT
more/RBR
detailed/JJ
survey/NN
and/CC
comparison/NN
of/IN
the/DT
tools/NNS
have/VBP
been/VBN
previously/RB
described/VBN
[/(
5/CD
,/,
21/CD
]/)
./.
====================
These/DT
procedures/NNS
typically/RB
take/VBP
the/DT
BAM/NN
files/NNS
from/IN
the/DT
``/NN
raw/NN
sequence/NN
processing/NN
and/CC
mapping/NN
''/CD
phase/NN
,/,
together/RB
with/IN
the/DT
reference/NN
genome/NN
sequence/NN
in/IN
a/DT
FASTA/NN
file/JJ
./.
====================
The/DT
output/JJ
file/JJ
from/IN
this/DT
step/NN
is/VBZ
usually/RB
in/IN
the/DT
standard/JJ
variant/JJ
call/NN
format/IN
(/(
VCF/NN
)/)
./.
====================
Some/DT
of/IN
the/DT
tools/NNS
allow/VBP
the/DT
user/NN
to/TO
specify/VB
known/VBN
variants/NNS
to/TO
optimize/VB
the/DT
variant/JJ
discovery/NN
./.
====================
For/IN
example/NN
,/,
GATK/NN
UnifiedGenotyper/JJ
uses/VBZ
known/VBN
variants/NNS
(/(
e.g./FW
,/,
from/IN
the/DT
dbSNP/NN
database/NN
)/)
as/IN
high-confidence/RB
datasets/NNS
to/TO
assist/VB
model/NN
training/VBG
./.
====================
After/IN
variant/JJ
and/CC
genotype/NN
calling/JJ
,/,
the/DT
probability/NN
scores/VBZ
of/IN
variants/NNS
are/VBP
recalibrated/VBN
,/,
and/CC
artifacts/NNS
are/VBP
identified/VBN
./.
====================
The/DT
artifacts/NNS
can/MD
be/VB
removed/VBN
subsequently/RB
either/CC
by/IN
filtering/VBG
the/DT
data/NNS
using/VBG
a/DT
series/NN
of/IN
criteria/NNS
or/CC
by/IN
building/VBG
and/CC
applying/VBG
an/DT
error/NN
model/NN
./.
====================
One/CD
example/NN
of/IN
the/DT
variant/JJ
discovery/NN
tool/NN
is/VBZ
the/DT
GATK/NN
UnifiedGenotyper/JJ
,/,
which/WDT
calls/NNS
variants/NNS
by/IN
examining/VBG
the/DT
reference/NN
genome/NN
base/NN
by/IN
base/NN
,/,
without/IN
correcting/VBG
misalignment/JJ
issues/NNS
./.
====================
This/DT
procedure/NN
could/MD
lead/VB
to/TO
false/VB
positive/JJ
calls/NNS
,/,
particularly/RB
in/IN
regions/NNS
containing/VBG
indels/VBZ
./.
====================
To/TO
increase/VB
the/DT
accuracy/NN
and/CC
sensitivity/NN
,/,
calling/JJ
multiple/JJ
samples/NNS
simultaneously/RB
is/VBZ
recommended/VBN
./.
====================
By/IN
taking/VBG
into/IN
account/VBP
the/DT
information/NN
of/IN
a/DT
variant/JJ
in/IN
a/DT
population/NN
,/,
the/DT
accuracy/NN
and/CC
sensitivity/NN
of/IN
variant/JJ
discovery/NN
are/VBP
greatly/RB
improved/JJ
,/,
especially/RB
for/IN
common/JJ
variants/NNS
[/(
16/CD
,/,
22/CD
]/)
./.
====================
The/DT
GATK/NN
Haplotype-Caller/NN
,/,
as/IN
compared/VBN
to/TO
the/DT
UnifiedGenotyper/JJ
,/,
calls/NNS
all/DT
variants/NNS
(/(
single/JJ
nucleotide/NN
polymorphisms/NNS
[/(
SNPs/NNS
]/)
,/,
indels/VBZ
,/,
structural/JJ
variations/NNS
,/,
etc/JJ
./.
)/)
====================
simultaneously/RB
by/IN
performing/VBG
local/JJ
de/FW
novo/FW
assembly/NN
of/IN
haplotypes/NNS
and/CC
emits/VBZ
more/RBR
accurate/JJ
call/JJ
sets/NNS
,/,
with/IN
the/DT
drawback/NN
of/IN
being/VBG
slower/JJR
./.
====================
In/IN
general/JJ
,/,
structural/JJ
variations/NNS
(/(
SVs/NNS
)/)
and/CC
copy/NN
number/NN
variations/NNS
(/(
CNVs/NNS
)/)
are/VBP
more/RBR
difficult/JJ
to/TO
detect/VB
than/IN
SNPs/NNS
and/CC
indels/VBZ
because/IN
of/IN
their/PRP$
heterogeneous/JJ
nature/NN
./.
====================
For/IN
SVs/NNS
and/CC
CNVs/NNS
,/,
it/PRP
is/VBZ
generally/RB
recommended/VBN
to/TO
apply/RB
a/DT
combination/NN
of/IN
several/JJ
tools/NNS
and/CC
take/VBP
the/DT
overlapping/VBG
variant/JJ
sites/NNS
for/IN
high-confidence/JJ
calls/NNS
[/(
17/CD
]/)
./.
====================
Genotype/NN
phasing/NN
and/CC
refinement/JJ
====================
After/IN
the/DT
initial/JJ
variant/JJ
discovery/NN
and/CC
recalibration/NN
,/,
variant/JJ
genotyping/VBG
and/or/CC
phasing/NN
are/VBP
performed/VBN
to/TO
provide/VB
critical/JJ
information/NN
for/IN
downstream/JJ
medical/JJ
and/CC
population/NN
genetic/JJ
studies/NNS
that/IN
require/VBP
accurate/VBP
haplotype/NN
structures/NNS
./.
====================
For/IN
example/NN
,/,
Mendelian/JJ
diseases/NNS
may/MD
be/VB
caused/VBN
by/IN
a/DT
compound/NN
heterozygote/NN
event/NN
where/WRB
heterogeneous/JJ
mutations/NNS
are/VBP
found/VBN
on/IN
different/JJ
chromosomes/NNS
./.
====================
In/IN
such/JJ
a/DT
scenario/NN
,/,
knowledge/NN
about/RB
the/DT
paternal/JJ
or/CC
maternal/JJ
origin/NN
of/IN
a/DT
variant/JJ
can/MD
provide/VB
valuable/JJ
information/NN
./.
====================
The/DT
GATK/NN
workflow/NN
recommends/VBZ
three/CD
steps/NNS
of/IN
genotype/NN
phasing/NN
:/:
transmission/NN
based/VBN
on/IN
pedigree/NN
,/,
haplotype/JJ
based/VBN
on/IN
reads/VBZ
,/,
and/CC
statistical/JJ
imputation/NN
./.
====================
GATK/NN
PhaseByTransmission/NN
incorporates/VBZ
pedigree/NN
data/NNS
to/TO
assist/VB
genotype/NN
calling/JJ
,/,
while/IN
GATK/NN
Read-BackedPhasing/VBG
performs/NNS
physical/JJ
phasing/NN
of/IN
variant/JJ
calling/JJ
based/VBN
on/IN
sequence/NN
reads/VBZ
./.
====================
Statistical/JJ
imputation/NN
of/IN
genotypes/NNS
can/MD
be/VB
processed/VBN
by/IN
several/JJ
programs/NNS
,/,
such/JJ
as/IN
Beagle/JJ
[/(
23,24/CD
]/)
,/,
IMPUTE2/NN
[/(
25/CD
]/)
,/,
and/CC
MACH/NN
[/(
26/CD
]/)
./.
====================
Phase/NN
3/CD
:/:
Disease/NN
gene/NN
filtering/VBG
and/or/CC
prioritization/NN
====================
Overview/NN
====================
A/DT
typical/JJ
variant/JJ
call/JJ
pipeline/NN
will/MD
produce/VB
approximately/RB
3/CD
million/NN
variants/NNS
from/IN
one/CD
whole-genome/JJ
sequencing/NN
data/NNS
set/VBP
and/CC
more/RBR
than/IN
20/CD
thousand/CC
variants/NNS
from/IN
one/CD
whole-exome/JJ
sequencing/NN
data/NNS
set/VBP
[/(
27/CD
]/)
./.
====================
Because/IN
disease/NN
causing/VBG
mutations/NNS
might/MD
just/RB
be/VB
several/JJ
``/NN
needles/NNS
''/CD
in/IN
this/DT
tremendous/JJ
``/CD
haystack/VBP
''/CD
of/IN
variants/NNS
,/,
rigorous/JJ
algorithms/NNS
and/CC
high-quality/JJ
databases/NNS
are/VBP
essential/JJ
to/TO
accurately/RB
locate/VBP
the/DT
candidate/NN
genes/NNS
./.
====================
This/DT
process/NN
is/VBZ
done/VBN
either/CC
by/IN
filtering/VBG
out/IN
variants/NNS
that/IN
are/VBP
not/RB
likely/JJ
to/TO
carry/JJ
a/DT
disease/NN
risk/NN
or/CC
by/IN
ranking/VBG
all/DT
variants/NNS
based/VBN
on/IN
biological/statistical/JJ
models/NNS
,/,
such/JJ
that/IN
high-risk/VBP
candidates/NNS
rank/VBP
at/IN
the/DT
top/NN
of/IN
the/DT
list/NN
[/(
1/CD
,/,
2/CD
,/,
4/CD
]/)
./.
====================
Unlike/IN
Phase/NN
1/CD
and/CC
Phase/NN
2/CD
,/,
which/WDT
have/VBP
largely/RB
converged/VBN
to/TO
well-formed/JJ
computation/NN
workflows/VBZ
and/CC
platform-free/JJ
file/JJ
formats/NNS
(/(
e.g./FW
,/,
FASTQ/NN
,/,
BAM/NN
,/,
and/CC
VCF/NN
formats/NNS
)/)
,/,
Phase/NN
3/CD
has/VBZ
more/RBR
variations/NNS
in/IN
the/DT
tools/NNS
and/CC
workflows/VBZ
to/TO
suit/VB
the/DT
different/JJ
needs/VBZ
of/IN
various/JJ
research/NN
or/CC
clinical/JJ
projects/NNS
./.
====================
Annotation/NN
====================
Although/IN
many/JJ
different/JJ
strategies/NNS
can/MD
be/VB
used/VBN
to/TO
search/VB
for/IN
disease-causing/VBG
mutations/NNS
,/,
some/DT
general/JJ
procedures/NNS
are/VBP
shared/VBN
./.
====================
The/DT
first/JJ
step/NN
,/,
variant/JJ
annotation/NN
,/,
typically/RB
investigates/VBZ
the/DT
potential/JJ
pathogenic/JJ
impact/NN
of/IN
a/DT
variant/JJ
,/,
before/IN
any/DT
subsequent/JJ
filtering/JJ
or/CC
prioritizing/JJ
./.
====================
The/DT
goal/NN
is/VBZ
to/TO
identify/VB
and/CC
report/VBP
the/DT
effect/NN
of/IN
each/DT
variant/JJ
with/IN
respect/NN
to/TO
predefined/JJ
``/CD
features/NNS
,/,
''/NNP
such/JJ
as/IN
genes/NNS
./.
====================
For/IN
example/NN
,/,
if/IN
a/DT
variant/JJ
(/(
SNP/NN
or/CC
indel/JJ
)/)
is/VBZ
present/JJ
within/IN
the/DT
coding/VBG
region/NN
,/,
the/DT
potential/JJ
effects/NNS
include/VBP
change/NN
to/TO
amino/NN
acid/NN
(/(
non-synonymous/JJ
)/)
,/,
no/DT
change/NN
to/TO
amino/NN
acid/NN
(/(
synonymous/JJ
)/)
,/,
introduction/NN
of/IN
stop/NN
codon/NN
(/(
stop/NN
gain/RB
)/)
,/,
removal/NN
of/IN
stop/NN
codon/NN
(/(
stop/NN
loss/NN
)/)
,/,
addition/removal/JJ
of/IN
amino-acid/JJ
(/(
s/NNS
)/)
(/(
inframe/RB
indel/RB
)/)
,/,
and/CC
change/NN
to/TO
the/DT
open/JJ
reading/NN
frame/NN
(/(
frame-shifting/VBG
indel/RB
)/)
,/,
etc/JJ
./.
====================
Other/JJ
than/IN
variant/JJ
call/JJ
files/NNS
,/,
the/DT
annotation/NN
process/NN
requires/VBZ
a/DT
feature/NN
file/JJ
that/DT
defines/VBZ
the/DT
location/NN
of/IN
genomic/JJ
features/NNS
(/(
e.g./FW
,/,
transcript/NN
,/,
exon/NN
,/,
intron/NN
,/,
etc/JJ
./.
====================
)/)
,/,
which/WDT
is/VBZ
usually/RB
in/IN
browser/JJR
extensible/JJ
data/NNS
(/(
BED/NN
)/)
format/IN
[/(
28/CD
]/)
,/,
or/CC
generic/JJ
feature/NN
format/IN
version/NN
3/CD
(/(
GFF3/NN
)/)
format/IN
maintained/VBD
by/IN
the/DT
Sequence/NN
Ontology/NN
project/VB
[/(
29/CD
]/)
./.
====================
In/IN
many/JJ
situations/NNS
,/,
the/DT
reference/NN
genome/NN
in/IN
FASTA/NN
format/IN
is/VBZ
also/RB
provided/VBD
as/IN
part/NN
of/IN
the/DT
input/NN
,/,
and/CC
the/DT
annotated/JJ
variants/NNS
are/VBP
likely/JJ
to/TO
be/VB
platform-specific/JJ
[/(
30/CD
,/,
31/CD
]/)
./.
====================
Annotation/NN
is/VBZ
part/NN
of/IN
the/DT
workflow/NN
for/IN
almost/RB
all/DT
variant/JJ
analysis/NN
tools/NNS
,/,
such/JJ
as/IN
the/DT
open/JJ
source/NN
software/RB
package/NN
VAAST/NN
[/(
31/CD
]/)
,/,
ANNOVAR/NN
[/(
27/CD
]/)
,/,
and/CC
many/JJ
commercial/JJ
service/RB
providers/NNS
(/(
e.g./FW
,/,
Ingenuity/NN
,/,
Golden/NNP
Helix/JJ
,/,
Geospiza/NNP
GeneSifter/NNP
,/,
Omicia/NNP
,/,
Seven/JJ
Bridges/NNS
Genomics/NNS
,/,
Biobase/NNP
,/,
etc/JJ
./.
)/)
./.
====================
Once/RB
the/DT
variants/NNS
are/VBP
annotated/VBN
,/,
a/DT
number/NN
of/IN
methods/NNS
can/MD
be/VB
used/VBN
to/TO
predict/VB
the/DT
severity/NN
of/IN
a/DT
variant/JJ
,/,
based/VBN
either/CC
on/IN
the/DT
protein/NN
sequence/NN
conservation/NN
information/NN
(/(
e.g./FW
,/,
BLOSOM62/NN
,/,
SIFT/NN
)/)
or/CC
the/DT
DNA/NN
sequence/NN
conservation/NN
information/NN
(/(
e.g./FW
,/,
PhastCons/NNS
)/)
./.
====================
The/DT
SIFT/NN
[/(
32/CD
]/)
score/RB
system/NN
assumes/VBZ
that/DT
protein/NN
``/CD
motifs/NNS
''/CD
or/CC
``/NN
sites/NNS
''/RB
are/VBP
functionally/RB
important/JJ
if/IN
they/PRP
are/VBP
highly/RB
conserved/VBN
across/IN
species/NNS
./.
====================
For/IN
example/NN
,/,
coding/VBG
regions/NNS
,/,
active/JJ
sites/NNS
of/IN
enzymes/NNS
,/,
many/JJ
splice/NN
sites/NNS
,/,
and/CC
promoters/NNS
are/VBP
usually/RB
conserved/VBN
across/IN
species/NNS
[/(
32/CD
]/)
./.
====================
Technically/RB
,/,
SIFT/NN
uses/VBZ
protein/NN
homology/NN
to/TO
calculate/JJ
position-specific/JJ
scores/VBZ
,/,
which/WDT
are/VBP
then/RB
used/VBN
to/TO
evaluate/VB
if/IN
an/DT
amino/NN
acid/NN
substitution/NN
at/IN
a/DT
specific/JJ
location/NN
is/VBZ
damaging/VBG
or/CC
tolerated/VBN
./.
====================
The/DT
accuracy/NN
of/IN
the/DT
SIFT/NN
prediction/NN
depends/VBZ
largely/RB
on/IN
the/DT
availability/NN
and/CC
the/DT
diversity/NN
of/IN
the/DT
homologous/JJ
sequences/NNS
across/IN
species/NNS
./.
====================
Therefore/RB
,/,
the/DT
application/NN
and/CC
accuracy/NN
of/IN
SIFT/NN
are/VBP
limited/JJ
if/IN
there/EX
is/VBZ
limited/JJ
homolog/NN
information/NN
or/CC
if/IN
the/DT
diversity/NN
is/VBZ
low/JJ
./.
====================
The/DT
BLOSUM62/NN
matrix/NN
[/(
33/CD
]/)
is/VBZ
a/DT
more/RBR
general-purpose/JJ
score/RB
system/NN
that/IN
is/VBZ
based/VBN
on/IN
the/DT
alignment/NN
of/IN
protein/NN
homologs/NNS
with/IN
a/DT
maximum/JJ
of/IN
62/CD
%/NN
identity/NN
./.
====================
The/DT
BLOSUM62/NN
matrix/NN
is/VBZ
then/RB
calculated/VBN
based/VBN
on/IN
the/DT
count/NN
of/IN
the/DT
observed/VBN
frequency/NN
of/IN
specific/JJ
amino/NN
acid/NN
substitutions/NNS
./.
====================
The/DT
PhastCons/NNS
score/RB
[/(
34/CD
]/)
is/VBZ
calculated/VBN
based/VBN
on/IN
DNA/NN
sequence/NN
conservation/NN
in/IN
a/DT
multiple/JJ
alignment/NN
./.
====================
It/PRP
uses/VBZ
a/DT
statistical/JJ
model/NN
of/IN
sequence/NN
evolution/NN
and/CC
considers/VBZ
the/DT
phylogeny/NN
relationship/NN
of/IN
multiple/JJ
species/NNS
./.
====================
Instead/RB
of/IN
measuring/VBG
the/DT
statistical/JJ
similarity/NN
and/CC
diversity/NN
in/IN
percent/JJ
identity/NN
,/,
PhastCons/NNS
uses/VBZ
a/DT
phylogenetic/JJ
Hidden/JJ
Markov/NNP
Model/NN
and/CC
provides/VBZ
base-by-base/NN
conservation/NN
scores/VBZ
./.
====================
Because/IN
the/DT
PhastCons/NNS
score/RB
is/VBZ
calculated/VBN
for/IN
each/DT
base/NN
,/,
it/PRP
can/MD
be/VB
applied/VBN
to/TO
regions/NNS
beyond/IN
the/DT
coding/VBG
sequence/NN
to/TO
provide/VB
valuable/JJ
information/NN
for/IN
prioritizing/VBG
non-coding/JJ
variants/NNS
./.
====================
In/IN
addition/NN
to/TO
the/DT
conservation/NN
information/NN
,/,
many/JJ
software/JJ
packages/NNS
also/RB
incorporate/VBP
protein/NN
structure/NN
information/NN
,/,
such/JJ
as/IN
the/DT
positions/NNS
of/IN
active/JJ
sites/NNS
and/CC
secondary/JJ
structures/NNS
,/,
into/IN
the/DT
prediction/NN
algorithm/NN
(/(
e.g./FW
,/,
Polyphen2/NN
,/,
SNAP/NN
)/)
./.
====================
Polyphen2/NN
[/(
35/CD
]/)
combines/NNS
eight/CD
sequencing/NN
features/NNS
(/(
e.g./FW
,/,
congruency/NN
of/IN
the/DT
variant/JJ
allele/NN
to/TO
the/DT
multiple/JJ
alignment/JJ
)/)
and/CC
three/CD
structural/JJ
features/NNS
(/(
e.g./FW
,/,
changes/NNS
in/IN
hydrophobic/JJ
propensity/NN
)/)
to/TO
score/VB
an/DT
amino/NN
acid/NN
substitution/NN
./.
====================
The/DT
homology/NN
search/NN
and/CC
model/NN
training/VBG
of/IN
Polyphen2/NN
are/VBP
based/VBN
on/IN
the/DT
UniProt/JJ
database/NN
./.
====================
It/PRP
worth/NN
noting/VBG
that/DT
Polyphen2/NN
provides/VBZ
two/CD
different/JJ
prediction/NN
models/NNS
that/DT
use/VBP
different/JJ
datasets/NNS
for/IN
training/VBG
,/,
with/IN
HumVar/JJ
tuned/JJ
to/TO
score/VB
Mendelian/JJ
diseases/NNS
and/CC
HumDiv/NNP
tuned/JJ
to/TO
evaluate/VB
rare/JJ
alleles/NNS
at/IN
loci/NNS
that/IN
are/VBP
potentially/RB
involved/VBN
in/IN
complex/NN
traits/VBZ
./.
====================
SNAP/NN
[/(
36/CD
]/)
is/VBZ
another/DT
tool/NN
that/DT
uses/VBZ
various/JJ
protein/NN
information/NN
,/,
such/JJ
as/IN
the/DT
secondary/JJ
structure/NN
and/CC
conservation/NN
,/,
to/TO
predict/VB
the/DT
functional/JJ
effect/NN
of/IN
a/DT
variant/JJ
./.
====================
Filtering/VBG
====================
After/IN
variant/JJ
annotation/NN
,/,
two/CD
types/NNS
of/IN
disease-gene/JJ
identification/NN
strategies/NNS
are/VBP
commonly/RB
employed/VBN
./.
====================
A/DT
filter-based/JJ
approach/NN
uses/VBZ
a/DT
series/NN
of/IN
criteria/NNS
to/TO
sort/VB
out/RP
variants/NNS
or/CC
genes/NNS
that/WDT
are/VBP
unlikely/JJ
to/TO
be/VB
causative/JJ
,/,
given/VBN
a/DT
disease/NN
model/NN
./.
====================
For/IN
example/NN
,/,
in/IN
a/DT
typical/JJ
workflow/NN
of/IN
ANNOVAR/NN
,/,
variants/NNS
that/WDT
overlap/VBP
with/IN
the/DT
1000/CD
Genome/NN
Project/NN
are/VBP
removed/VBN
from/IN
the/DT
list/NN
./.
====================
Since/IN
the/DT
1000/CD
Genome/NN
Project/JJ
aimed/VBD
to/TO
identify/VB
common/JJ
SNPs/NNS
with/IN
a/DT
minor/JJ
allele/NN
frequency/NN
(/(
MAF/NN
)/)
greater/JJR
than/IN
1/CD
%/NN
,/,
these/DT
variants/NNS
are/VBP
thought/VBN
to/TO
be/VB
``/CD
benign/JJ
''/NNP
in/IN
a/DT
rare/JJ
Mendelian/JJ
disease/NN
,/,
under/IN
the/DT
assumption/NN
that/DT
the/DT
causing/VBG
mutation/NN
of/IN
a/DT
rare/JJ
disease/NN
should/MD
have/VBP
a/DT
very/RB
low/JJ
MAF/NN
./.
====================
The/DT
HapMap/NN
[/(
37/CD
,/,
38/CD
]/)
database/NN
,/,
which/WDT
intended/VBD
to/TO
identify/VB
haplotype-defining/VBG
variants/NNS
in/IN
different/JJ
populations/NNS
,/,
can/MD
also/RB
be/VB
used/VBN
for/IN
variant/JJ
selection/NN
./.
====================
In/IN
some/DT
cases/NNS
,/,
high/JJ
frequency/NN
of/IN
a/DT
haplotype/JJ
can/MD
be/VB
related/JJ
to/TO
a/DT
specific/JJ
disease/NN
,/,
and/CC
can/MD
help/VB
researchers/NNS
focus/FW
on/IN
a/DT
subset/NN
of/IN
variants/NNS
within/IN
a/DT
specific/JJ
region/NN
./.
====================
Another/DT
commonly/RB
applied/VBN
filter/NN
is/VBZ
to/TO
exclude/VB
non-coding/JJ
variants/NNS
under/IN
the/DT
assumption/NN
that/DT
a/DT
disease-causing/JJ
mutation/NN
should/MD
occur/VB
in/IN
the/DT
coding/VBG
regions/NNS
and/CC
affect/VB
protein/NN
sequences/NNS
./.
====================
Several/JJ
other/JJ
filtering/JJ
criteria/NNS
are/VBP
also/RB
commonly/RB
used/VBN
,/,
such/JJ
as/IN
filtering/VBG
variants/NNS
with/IN
little/JJ
predicted/VBN
functional/JJ
impact/NN
(/(
e.g./FW
,/,
synonymous/JJ
variants/NNS
)/)
or/CC
having/VBG
low-quality/NN
scores/VBZ
(/(
e.g./FW
,/,
low/JJ
read-depth/NN
or/CC
low/JJ
genotype/NN
quality/NN
score/RB
)/)
./.
====================
A/DT
disease/NN
model/NN
can/MD
also/RB
help/VBP
filter/JJR
variants/NNS
./.
====================
For/IN
example/NN
,/,
a/DT
disease/NN
under/IN
a/DT
recessive/JJ
mode/NN
of/IN
inheritance/NN
requires/VBZ
more/RBR
than/IN
one/CD
deleterious/JJ
variant/JJ
in/IN
a/DT
gene/NN
./.
====================
The/DT
filtering/JJ
strategy/NN
is/VBZ
intuitive/JJ
and/CC
easy/RB
to/TO
perform/VB
and/CC
has/VBZ
been/VBN
successful/JJ
in/IN
early/JJ
whole-genome/exome/JJ
studies/NNS
on/IN
rare/JJ
,/,
single-gene/JJ
Mendelian/JJ
diseases/NNS
./.
====================
Numerous/JJ
tools/NNS
have/VBP
been/VBN
developed/VBN
to/TO
apply/RB
various/JJ
filtering/JJ
strategies/NNS
(/(
reviewed/VBD
in/IN
[/(
1/CD
,/,
2/CD
,/,
4/CD
,/,
5/CD
]/)
)/)
./.
====================
However/RB
,/,
caution/NN
should/MD
be/VB
taken/VBN
when/WRB
studying/VBG
common/JJ
,/,
complex/NN
diseases/NNS
,/,
because/IN
applying/VBG
hard/VBP
filters/NNS
could/MD
remove/VB
real/JJ
casual/JJ
variants/NNS
./.
====================
For/IN
instance/NN
,/,
common/JJ
diseases/NNS
could/MD
be/VB
caused/VBN
by/IN
common/JJ
variants/NNS
that/DT
have/VBP
incomplete/JJ
penetrance/NN
(/(
i.e./FW
,/,
not/RB
all/DT
individuals/NNS
carrying/VBG
the/DT
variant/JJ
will/MD
have/VBP
the/DT
disease/NN
)/)
./.
====================
Ranking/JJ
====================
To/TO
overcome/VB
the/DT
difficulties/NNS
associated/VBN
with/IN
hard/JJ
filtering/VBG
,/,
a/DT
prioritizing/JJ
approach/NN
ranks/VBZ
each/DT
gene/NN
or/CC
feature/NN
based/VBN
on/IN
the/DT
cumulative/JJ
disease/NN
risk/NN
of/IN
potential/JJ
deleterious/JJ
variants/NNS
./.
====================
As/IN
an/DT
example/NN
,/,
the/DT
VAAST/NN
tool/NN
kit/NN
performs/NNS
the/DT
composite/JJ
likelihood/NN
ratio/NN
test/NN
to/TO
determine/VB
the/DT
risk/NN
of/IN
a/DT
gene/NN
or/CC
a/DT
feature/NN
[/(
30/CD
,/,
31/CD
]/)
./.
====================
Information/NN
of/IN
each/DT
variant/JJ
within/IN
the/DT
gene/NN
,/,
such/JJ
as/IN
the/DT
predicted/VBN
biological/JJ
impact/NN
,/,
allele/NN
frequency/NN
,/,
and/CC
the/DT
conservation/NN
score/RB
of/IN
the/DT
variant/JJ
allele/NN
,/,
is/VBZ
considered/VBN
simultaneously/RB
under/IN
a/DT
likelihood/JJ
framework/NN
./.
====================
One/CD
advantage/NN
is/VBZ
that/DT
it/PRP
reduces/VBZ
the/DT
risk/NN
of/IN
filtering/VBG
out/RP
potential/JJ
risky/JJ
coding/VBG
variants/NNS
,/,
since/IN
there/EX
are/VBP
no/DT
hard/JJ
filtering/VBG
steps/NNS
./.
====================
Another/DT
advantage/NN
is/VBZ
that/DT
it/PRP
can/MD
score/VB
all/DT
variants/NNS
,/,
including/VBG
non-coding/JJ
variants/NNS
that/WDT
would/MD
have/VBP
otherwise/RB
been/VBN
filtered/VBN
out/RP
./.
====================
The/DT
statistical/JJ
framework/NN
used/VBN
by/IN
VAAST/NN
considers/VBZ
two/CD
sets/NNS
of/IN
information/NN
:/:
1/CD
)/)
the/DT
likelihood/JJ
of/IN
observing/VBG
the/DT
MAF/NN
of/IN
a/DT
variant/JJ
under/IN
a/DT
disease/NN
model/NN
versus/CC
a/DT
non-disease/JJ
model/NN
;/:
and/CC
2/CD
)/)
the/DT
likelihood/JJ
that/DT
a/DT
variant/JJ
is/VBZ
deleterious/JJ
versus/CC
non-deleterious/JJ
./.
====================
A/DT
combination/NN
of/IN
the/DT
observed/VBN
frequency/NN
and/CC
predicted/VBN
functional/JJ
impact/NN
of/IN
variants/NNS
is/VBZ
used/VBN
to/TO
assess/VB
the/DT
disease/NN
risk/NN
of/IN
a/DT
gene/NN
./.
====================
A/DT
practical/JJ
consideration/NN
is/VBZ
that/DT
most/JJS
variants/NNS
in/IN
the/DT
sequencing/NN
study/NN
are/VBP
rare/JJ
and/CC
may/MD
be/VB
difficult/JJ
to/TO
achieve/VB
sufficient/JJ
power/JJR
for/IN
a/DT
statistical/JJ
model/NN
[/(
39/CD
]/)
./.
====================
To/TO
overcome/VB
this/DT
,/,
a/DT
common/JJ
solution/NN
is/VBZ
to/TO
assess/VB
the/DT
cumulative/JJ
effects/NNS
of/IN
multiple/JJ
variants/NNS
in/IN
a/DT
defined/VBN
genomic/JJ
region/NN
,/,
such/JJ
as/IN
a/DT
gene/NN
or/CC
an/DT
exon/NN
[/(
39-41/CD
]/)
./.
====================
This/DT
approach/NN
evaluates/VBZ
the/DT
overall/JJ
genetic/JJ
burden/NN
of/IN
multiple/JJ
rare/JJ
variants/NNS
and/CC
is/VBZ
referred/VBN
to/TO
as/IN
the/DT
burden/NN
test/NN
./.
====================
Two/CD
general/JJ
methods/NNS
are/VBP
commonly/RB
used/VBN
to/TO
collapse/NN
multiple/JJ
rare/JJ
variants/NNS
[/(
40/CD
]/)
,/,
known/VBN
as/IN
the/DT
cohort/NN
allelic/JJ
sum/NN
test/NN
(/(
CAST/NN
)/)
and/CC
combined/JJ
multivariate/JJ
and/CC
collapsing/JJ
(/(
CMC/NN
)/)
method/NN
./.
====================
The/DT
CAST/NN
method/NN
measures/VBZ
the/DT
differences/NNS
(/(
between/IN
case/NN
group/NN
and/CC
control/JJ
group/NN
)/)
in/IN
the/DT
number/NN
of/IN
individuals/NNS
who/WP
carry/VBP
one/CD
or/CC
more/RBR
rare/JJ
variants/NNS
[/(
39/CD
,/,
42/CD
]/)
,/,
while/IN
the/DT
CMC/NN
method/NN
treats/NNS
all/DT
rare/JJ
variants/NNS
as/IN
a/DT
single/JJ
count/NN
for/IN
analysis/NN
with/IN
common/JJ
variants/NNS
[/(
39/CD
]/)
./.
====================
Since/IN
both/CC
methods/NNS
implicitly/RB
assume/NN
that/DT
all/DT
variants/NNS
influence/VBP
the/DT
phenotype/NN
in/IN
the/DT
same/JJ
direction/NN
[/(
39/CD
,/,
40/CD
]/)
,/,
it/PRP
could/MD
introduce/VB
substantial/JJ
noise/RB
if/IN
a/DT
lot/JJ
of/IN
the/DT
rare/JJ
variants/NNS
are/VBP
neutral/JJ
[/(
40/CD
]/)
./.
====================
Alternatives/RB
to/TO
these/DT
two/CD
basic/JJ
methods/NNS
are/VBP
also/RB
available/JJ
[/(
40/CD
]/)
./.
====================
For/IN
example/NN
,/,
by/IN
default/NN
,/,
the/DT
VAAST/NN
program/NN
combines/NNS
all/DT
variants/NNS
that/WDT
have/VBP
less/RBR
than/IN
three/CD
copies/NNS
in/IN
a/DT
gene/NN
into/IN
one/CD
pseudo-site/NN
for/IN
scoring/VBG
./.
====================
Pathway/NN
analysis/NN
====================
Pathway/NN
analysis/NN
is/VBZ
an/DT
alternative/JJ
way/NN
to/TO
search/VB
for/IN
deleterious/JJ
genes/NNS
./.
====================
The/DT
assumption/NN
is/VBZ
that/DT
a/DT
single/JJ
mutation/NN
in/IN
a/DT
single/JJ
gene/NN
may/MD
not/RB
be/VB
very/RB
harmful/JJ
but/CC
that/IN
a/DT
combination/NN
of/IN
mutations/NNS
in/IN
several/JJ
genes/NNS
causes/VBZ
the/DT
disease/NN
./.
====================
In/IN
this/DT
type/NN
of/IN
analysis/NN
,/,
variants/NNS
are/VBP
put/JJ
in/IN
a/DT
context/NN
of/IN
biological/JJ
processes/NNS
,/,
pathways/NNS
,/,
and/CC
networks/NNS
to/TO
gain/VB
global/JJ
perspective/JJ
on/IN
the/DT
data/NNS
./.
====================
A/DT
large/JJ
number/NN
of/IN
knowledge/NN
bases/NNS
and/CC
tools/NNS
have/VBP
been/VBN
developed/VBN
for/IN
this/DT
task/NN
(/(
reviewed/VBD
in/IN
[/(
43/CD
,/,
44/CD
]/)
)/)
./.
====================
In/IN
general/JJ
,/,
pathway/NN
systems/NNS
contain/VBP
a/DT
curation/NN
process/NN
that/DT
is/VBZ
either/CC
manual/JJ
or/CC
automatic/JJ
,/,
followed/VBN
by/IN
database/NN
assembly/NN
and/CC
refinement/JJ
[/(
43/CD
]/)
./.
====================
Many/JJ
public/JJ
knowledge/NN
base/NN
and/CC
analysis/NN
tools/NNS
are/VBP
available/JJ
,/,
such/JJ
as/IN
Kyoto/JJ
Encyclopedia/NN
of/IN
Genes/NNS
and/CC
Genomes/NNS
(/(
KEGG/NN
)/)
(/(
http/NN
:/:
//www.kegg.jp//JJ
)/)
;/:
BioCyc/NNP
(/(
http/NN
:/:
//www.biocyc.org//JJ
)/)
,/,
provided/VBD
by/IN
SRI/NN
international/JJ
;/:
PANTHER/NN
[/(
45/CD
]/)
;/:
Reactome/DT
[/(
46/CD
]/)
;/:
and/CC
DAVID/NN
[/(
47/CD
]/)
./.
====================
Optionally/RB
,/,
commercial/JJ
systems/NNS
,/,
such/JJ
as/IN
Ingenuity/NN
Pathway/NN
Analysis/NN
(/(
http/NN
:/:
//www.ingenuity.com/products/ipa/NN
)/)
,/,
Pathway/NN
Studio/NN
(/(
http/NN
:/:
//www.elsevier.com/online-tools/pathway-studio/DT
)/)
,/,
and/CC
GeneGo/NN
(/(
http/NN
:/:
//portal.genego.com//JJ
)/)
,/,
are/VBP
also/RB
available/JJ
./.
====================
Ingenuity/NN
Variant/JJ
Analysis/NN
(/(
http/NN
:/:
//www.ingenuity.com/products/variant-analysis/NN
)/)
is/VBZ
also/RB
backed/VBD
up/IN
with/IN
Ingenuity/NN
Knowledge/NN
Base/NN
and/CC
can/MD
consider/VB
the/DT
upstream/JJ
and/CC
downstream/JJ
genes/NNS
of/IN
a/DT
variant/JJ
in/IN
a/DT
pathway/NN
and/CC
evaluate/VBP
the/DT
potential/JJ
role/NN
of/IN
a/DT
gene/NN
by/IN
incorporating/VBG
the/DT
related/JJ
genes/NNS
./.
====================
To/TO
help/VB
readers/VBZ
who/WP
have/VBP
limited/VBN
experience/VBP
with/IN
NGS/NN
data/NNS
to/TO
understand/VB
the/DT
workflow/NN
,/,
in/IN
this/DT
section/NN
we/PRP
will/MD
show/VBP
a/DT
real/JJ
example/NN
of/IN
a/DT
pipeline/JJ
that/DT
was/VBD
used/VBN
to/TO
process/NN
whole-exome/DT
sequencing/NN
data/NNS
from/IN
raw/JJ
sequences/NNS
to/TO
a/DT
ranked/JJ
candidate/NN
gene/NN
list/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
The/DT
pipeline/NN
is/VBZ
constructed/VBN
,/,
based/VBN
on/IN
the/DT
three-phase/NN
organization/NN
,/,
as/IN
described/VBN
in/IN
the/DT
previous/JJ
sections/NNS
./.
====================
We/PRP
start/VBP
from/IN
raw/NN
sequence/NN
FASTQ/NN
files/NNS
and/CC
assume/NN
no/DT
quality/NN
control/NN
has/VBZ
been/VBN
performed/VBN
or/CC
reported/VBN
./.
====================
Please/NN
note/NN
that/IN
each/DT
tool/NN
is/VBZ
likely/JJ
to/TO
require/VB
dependent/JJ
files/NNS
,/,
such/JJ
as/IN
the/DT
reference/NN
genome/NN
,/,
the/DT
1000/CD
Genome/NN
variants/NNS
,/,
dbSNP/NN
variants/NNS
,/,
and/CC
the/DT
genome/NN
feature/NN
file/JJ
in/IN
GFF3/NN
format/IN
,/,
etc/JJ
./.
====================
Sequence/NN
mapping/NN
====================
-/:
Raw/NN
sequence/NN
quality/NN
control/NN
./.
====================
FastQC/NN
can/MD
be/VB
used/VBN
to/TO
perform/VB
graphical/JJ
quality/NN
checks/NNS
on/IN
the/DT
raw/NN
sequence/NN
./.
====================
FastX/NN
can/MD
be/VB
used/VBN
to/TO
filter/NN
the/DT
reads/VBZ
by/IN
specifying/VBG
quality/NN
score/RB
ranges/VBZ
./.
====================
-/:
Initial/JJ
mapping/NN
./.
====================
BWA/NN
is/VBZ
recommended/VBN
for/IN
mapping/VBG
Illumina/NN
reads/VBZ
./.
====================
The/DT
first/JJ
step/NN
of/IN
BWA/NN
is/VBZ
to/TO
generate/VB
suffix/JJ
array/NN
coordinates/VBZ
for/IN
mapping/VBG
the/DT
reads/VBZ
;/:
then/RB
,/,
one/CD
performs/NNS
the/DT
actual/JJ
alignment/NN
and/CC
outputs/NNS
SAM/NN
format/IN
files/NNS
./.
====================
The/DT
SAM/NN
file/JJ
is/VBZ
converted/VBN
to/TO
BAM/NN
format/IN
,/,
sorted/VBN
,/,
and/CC
indexed/VBD
using/VBG
Samtools/NNS
for/IN
faster/JJR
downstream/JJ
processing/NN
(/(
sorting/NN
is/VBZ
often/RB
required/VBN
by/IN
many/JJ
downstream/JJ
tools/NNS
)/)
./.
====================
-/:
Alignment/JJ
recalibration/NN
./.
====================
The/DT
GATK/NN
RealignerTarget-Creator/NN
tool/NN
is/VBZ
used/VBN
to/TO
create/VB
target/NN
regions/NNS
for/IN
realignment/JJ
,/,
followed/VBN
by/IN
the/DT
IndelRealigner/NN
tool/NN
to/TO
perform/VB
the/DT
actual/JJ
realignment/JJ
and/CC
output/IN
new/JJ
BAMs/NNS
./.
====================
The/DT
Picard/NN
MarkDuplicates/NNS
tool/NN
is/VBZ
then/RB
used/VBN
to/TO
mark/VB
and/CC
remove/VB
duplicated/JJ
sequences/NNS
,/,
followed/VBN
by/IN
the/DT
Picard/NN
BuildBamIndex/NN
tool/NN
to/TO
rebuild/JJ
the/DT
index/NN
./.
====================
Next/RB
,/,
GATK/NN
's/POS
BaseRecalibrator/NN
tool/NN
is/VBZ
used/VBN
to/TO
recalibrate/VB
the/DT
base/NN
quality/NN
scores/VBZ
,/,
and/CC
PrintReads/VBZ
is/VBZ
used/VBN
to/TO
output/VB
the/DT
final/JJ
,/,
analysis-ready/RB
reads/VBZ
in/IN
BAM/NN
format/IN
./.
====================
Variant/JJ
discovery/NN
====================
-/:
Initial/JJ
variant/JJ
discovery/NN
./.
====================
The/DT
GATK/NN
UnifiedGenotyper/JJ
tool/NN
is/VBZ
used/VBN
to/TO
perform/VB
initial/JJ
raw/NN
variant/JJ
calling/JJ
and/CC
output/NN
VCF/NN
files/NNS
./.
====================
-/:
Variant/JJ
recalibration/NN
and/CC
filtering/JJ
./.
====================
SNPs/NNS
and/CC
indels/VBZ
are/VBP
processed/VBN
separately/RB
but/CC
in/IN
a/DT
similar/JJ
manner/NN
;/:
so/RB
,/,
we/PRP
will/MD
only/RB
describe/VBP
SNPs/NNS
as/IN
an/DT
example/NN
./.
====================
The/DT
GATK/NN
Select-Variants/NNS
tool/NN
is/VBZ
used/VBN
to/TO
select/VB
SNPs/NNS
within/IN
the/DT
exome/JJ
regions/NNS
from/IN
raw/NN
VCF/NN
files/NNS
./.
====================
The/DT
VariantRecalibrator/NN
tool/NN
is/VBZ
then/RB
used/VBN
to/TO
build/JJ
Gaussian/JJ
models/NNS
for/IN
recalibration/NN
,/,
followed/VBN
by/IN
the/DT
ApplyRecalibration/NN
tool/NN
to/TO
apply/RB
models/NNS
for/IN
SNP/NN
recalibration/NN
./.
====================
Low-quality/JJ
SNPs/NNS
are/VBP
then/RB
removed/VBD
by/IN
imposing/VBG
a/DT
filtering/JJ
step/NN
,/,
based/VBN
on/IN
a/DT
user-defined/JJ
variant/JJ
quality/NN
score/RB
recalibration/NN
(/(
VQSR/NN
)/)
score/VBP
threshold/NN
./.
====================
After/IN
SNPs/NNS
and/CC
indels/VBZ
are/VBP
reprocessed/VBN
,/,
the/DT
GATK/NN
CombineVariants/NNS
tool/NN
is/VBZ
used/VBN
to/TO
combine/VB
the/DT
recalibrated/JJ
SNPs/NNS
and/CC
indels/VBZ
./.
====================
Disease/NN
gene/NN
prioritization/NN
====================
-/:
Variant/JJ
annotation/NN
./.
====================
VCF/NN
files/NNS
are/VBP
converted/VBN
to/TO
genome/NN
variation/NN
format/IN
(/(
GVF/NN
)/)
format/VBP
using/VBG
the/DT
VAAST/NN
vaast_converter/NN
tool/NN
./.
====================
The/DT
variants/NNS
are/VBP
then/RB
annotated/JJ
using/VBG
the/DT
VAAST/NN
VAT/NN
tool/NN
./.
====================
-/:
Variant/JJ
selection/NN
./.
====================
The/DT
annotated/JJ
variants/NNS
are/VBP
selected/VBN
and/CC
condensed/VBD
to/TO
condenser/VB
(/(
CDR/NN
)/)
format/VBP
using/VBG
the/DT
VAAST/NN
VST/NN
tool/NN
for/IN
cases/NNS
and/CC
controls/VBZ
,/,
respectively/RB
./.
====================
-/:
Gene/NN
prioritization/NN
./.
====================
VAAST/NN
is/VBZ
used/VBN
to/TO
perform/VB
disease/NN
gene/NN
ranking/VBG
and/CC
output/NN
a/DT
text/JJ
file/JJ
containing/VBG
a/DT
list/NN
of/IN
ranked/JJ
candidate/NN
genes/NNS
./.
====================
High-throughput/JJ
data/NNS
processing/NN
and/CC
analysis/NN
are/VBP
becoming/VBG
reliable/JJ
and/CC
efficient/JJ
,/,
thanks/VBZ
to/TO
numerous/JJ
high-quality/JJ
tools/NNS
that/DT
are/VBP
mostly/RB
open/JJ
source/NN
,/,
with/IN
long-term/JJ
active/JJ
support/VBP
and/CC
frequent/JJ
updates/VBZ
to/TO
incorporate/VB
new/JJ
advances/NNS
in/IN
the/DT
field/NN
./.
====================
A/DT
typical/JJ
workflow/NN
covering/VBG
all/DT
three/CD
phases/NNS
outlined/VBN
above/IN
involves/VBZ
many/JJ
different/JJ
tools/NNS
and/or/CC
steps/NNS
,/,
databases/NNS
,/,
score/RB
systems/NNS
,/,
and/CC
file/JJ
re-formatting/VBG
steps/NNS
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
not/RB
a/DT
trivial/JJ
task/NN
to/TO
perform/VB
a/DT
data/NNS
processing/NN
task/NN
,/,
starting/VBG
from/IN
the/DT
raw/NN
FASTQ/NN
files/NNS
to/TO
the/DT
identification/NN
of/IN
candidate/NN
genes/NNS
./.
====================
There/EX
are/VBP
many/JJ
tools/NNS
and/CC
dependencies/VBZ
of/IN
tools/NNS
that/DT
need/VBD
to/TO
be/VB
installed/VBN
and/CC
many/JJ
steps/NNS
and/CC
many/JJ
parameters/NNS
that/WDT
need/VBD
to/TO
be/VB
specified/VBN
./.
====================
This/DT
could/MD
be/VB
a/DT
big/NN
hurdle/JJ
for/IN
researchers/NNS
that/WDT
have/VBP
limited/VBN
experience/VBP
with/IN
NGS/NN
data/NNS
pipelines/NNS
./.
====================
It/PRP
would/MD
be/VB
a/DT
good/JJ
idea/NN
for/IN
the/DT
community/NN
to/TO
converge/VB
on/IN
several/JJ
standardized/VBD
,/,
well-configured/JJ
,/,
project-optimized/VBD
,/,
and/CC
automated/JJ
workflows/VBZ
that/DT
can/MD
be/VB
used/VBN
widely/RB
with/IN
minimum/JJ
user/NN
interface/NN
./.
====================
HugeSeq/NNP
[/(
17/CD
]/)
by/IN
Stanford/NN
is/VBZ
a/DT
comprehensive/JJ
,/,
automated/JJ
workflow/NN
that/DT
integrates/VBZ
around/IN
two/CD
dozen/JJ
bioinformatics/NNS
tools/NNS
and/CC
can/MD
process/VB
FASTQ/FASTA/NN
files/NNS
,/,
perform/VBP
various/JJ
quality/NN
control/NN
and/CC
clean-ups/NNS
,/,
and/CC
output/IN
variant/JJ
call/JJ
files/NNS
./.
====================
Commercial/JJ
services/VBZ
,/,
such/JJ
as/IN
Seven/JJ
Bridges/NNS
Genomics/NNS
and/CC
Geospiza/NN
,/,
also/RB
have/VBP
preconfigured/VBN
,/,
comprehensive/JJ
,/,
automated/JJ
pipelines/NNS
for/IN
their/PRP$
customers/NNS
./.
====================
Flexibility/NN
of/IN
pipelines/NNS
,/,
on/IN
the/DT
other/JJ
hand/NN
,/,
may/MD
be/VB
important/JJ
for/IN
researchers/NNS
who/WP
want/JJ
to/TO
have/VB
complete/JJ
control/NN
on/IN
the/DT
pipeline/NN
design/NN
to/TO
fit/VB
their/PRP$
projects/NNS
./.
====================
In/IN
such/JJ
cases/NNS
,/,
it/PRP
is/VBZ
important/JJ
to/TO
have/VB
plasticity/NN
for/IN
users/NNS
to/TO
customize/VB
pipelines/NNS
./.
====================
For/IN
example/NN
,/,
a/DT
flexible/JJ
pipeline/NN
system/NN
should/MD
allow/VB
users/NNS
to/TO
integrate/VB
specific/JJ
tools/NNS
that/DT
are/VBP
not/RB
part/NN
of/IN
a/DT
general/JJ
purpose/NN
workflow/NN
and/CC
allow/VBP
users/NNS
to/TO
supply/RB
user-defined/VBN
control/NN
files/NNS
(/(
e.g./FW
,/,
providing/VBG
a/DT
BED/NN
file/JJ
to/TO
restrict/VB
the/DT
variant/JJ
call/JJ
within/IN
specific/JJ
regions/NNS
)/)
./.
====================
There/EX
are/VBP
a/DT
number/NN
of/IN
such/JJ
pipelines/NNS
that/DT
are/VBP
well/RB
defined/VBN
and/CC
easy/RB
to/TO
use/VB
,/,
such/JJ
as/IN
the/DT
GATK/NN
pipeline/NN
,/,
gkno/DT
system/NN
(/(
http/NN
:/:
//gkno.me//JJ
)/)
,/,
Galaxy/NNP
[/(
48-50/CD
]/)
,/,
and/CC
VAAST/NN
[/(
30/CD
,/,
31/CD
]/)
./.
====================
Highly/RB
efficient/JJ
and/CC
accurate/VBP
bioinformatics/NNS
tools/NNS
are/VBP
available/JJ
for/IN
most/JJS
of/IN
the/DT
steps/NNS
for/IN
analyzing/VBG
sequence/NN
data/NNS
,/,
from/IN
processing/NN
the/DT
raw/NN
NGS/NN
data/NNS
to/TO
generating/VBG
the/DT
final/JJ
report/NN
of/IN
potential/JJ
risk/NN
genes/NNS
./.
====================
Users/NNS
can/MD
choose/VB
automated/JJ
workflow/NN
versus/CC
customized/VBN
pipelines/NNS
to/TO
suit/VB
their/PRP$
research/NN
projects/NNS
./.
====================
Many/JJ
bioinformatics/NNS
tools/NNS
are/VBP
optimized/VBN
,/,
such/JJ
that/IN
a/DT
small/JJ
server/RB
(/(
e.g./FW
,/,
48/CD
cores/NNS
,/,
250/CD
GB/NN
RAM/NN
,/,
2/CD
TB/NN
storage/NN
)/)
can/MD
perform/VB
the/DT
whole/JJ
analysis/NN
workflow/IN
within/IN
a/DT
reasonable/JJ
time/NN
(/(
e.g./FW
,/,
250/CD
hours/NNS
in/IN
nonparallel/JJ
mode/NN
and/CC
25/CD
hours/NNS
in/IN
parallel/JJ
mode/NN
for/IN
one/CD
exome/JJ
at/IN
30/CD
coverage/JJ
,/,
as/IN
benchmarked/VBN
by/IN
HugeSeq/NNP
)/)
./.
====================
Furthermore/RB
,/,
the/DT
scientific/JJ
community/NN
is/VBZ
converging/VBG
towards/IN
standard/JJ
workflows/VBZ
and/CC
standard/JJ
file/JJ
formats/NNS
,/,
crossing/VBG
different/JJ
research/NN
institutes/NNS
,/,
companies/VBZ
,/,
and/CC
platforms/NNS
./.
====================
Several/JJ
file/JJ
formats/NNS
are/VBP
becoming/VBG
standard/JJ
,/,
such/JJ
as/IN
FASTQ/FASTA/NN
,/,
SAM/NN
,/,
BAM/NN
,/,
VCF/NN
,/,
and/CC
GFF3/NN
./.
====================
Large/JJ
publically/RB
funded/VBD
projects/NNS
,/,
such/JJ
as/IN
the/DT
1000/CD
Genome/NN
Project/JJ
,/,
the/DT
HapMap/NN
Project/JJ
,/,
and/CC
the/DT
NHLBI/NN
GO/NN
Exome/NN
Sequencing/NN
Project/JJ
,/,
have/VBP
played/VBN
important/JJ
roles/NNS
in/IN
the/DT
unification/JJ
process/NN
./.
====================
Nevertheless/RB
,/,
many/JJ
challenges/NNS
remain/VBP
,/,
and/CC
we/PRP
would/MD
like/IN
to/TO
highlight/VB
a/DT
few/JJ
:/:
1/CD
)/)
data/NNS
standards/VBZ
still/RB
need/VBD
wider/JJR
agreement/NN
./.
====================
For/IN
example/NN
,/,
a/DT
number/NN
of/IN
variant/JJ
discovery/RB
tools/NNS
for/IN
SV/NN
and/CC
CNV/NN
use/IN
different/JJ
file/JJ
formats/NNS
and/CC
need/RB
to/TO
be/VB
converted/VBN
to/TO
the/DT
more/RBR
standard/JJ
format/IN
for/IN
downstream/JJ
analysis/NN
[/(
17/CD
]/)
;/:
2/LS
)/)
more/RBR
standardized/VBN
,/,
automated/JJ
workflows/VBZ
need/RB
to/TO
be/VB
developed/VBN
to/TO
accommodate/VB
different/JJ
data/NNS
and/CC
projects/VBZ
and/CC
minimize/VBP
the/DT
user/NN
interaction/NN
,/,
such/JJ
that/IN
different/JJ
research/NN
groups/NNS
can/MD
perform/VB
independent/JJ
data/NNS
analysis/NN
and/CC
the/DT
results/NNS
can/MD
be/VB
easily/RB
compared/VBN
;/:
and/CC
3/CD
)/)
large/JJ
,/,
high-quality/JJ
,/,
and/CC
unified/JJ
databases/NNS
are/VBP
essential/JJ
for/IN
disease/NN
gene/NN
identification/prioritization/NN
,/,
and/CC
continuous/JJ
efforts/NNS
from/IN
the/DT
scientific/JJ
community/NN
are/VBP
needed/VBN
./.
====================
In/IN
addition/NN
to/TO
the/DT
challenges/NNS
,/,
a/DT
number/NN
of/IN
improvements/NNS
that/DT
are/VBP
urgently/RB
needed/VBD
for/IN
current/JJ
analysis/NN
pipeline/NN
are/VBP
being/VBG
actively/RB
developed/VBD
and/CC
implemented/VBD
:/:
====================
-/:
Sequence/NN
mapping/NN
./.
====================
Apply/RB
haplotype-based/VBD
mapping/NN
and/CC
de/FW
novo/FW
assembly/NN
to/TO
reduce/VB
mismatches/NNS
and/CC
increasing/VBG
specificity/NN
./.
====================
-/:
Variant/JJ
discovery/NN
and/CC
genotyping/VBG
./.
====================
Improve/JJ
the/DT
sequencing/NN
technology/NN
(/(
e.g./FW
,/,
longer/RBR
read/RB
length/NN
)/)
and/CC
analytical/JJ
methods/NNS
(/(
e.g./FW
,/,
de/FW
novo/FW
assembly-based/VBN
variant/JJ
discovery/NN
)/)
to/TO
identify/VB
and/CC
infer/VBP
genotypes/NNS
of/IN
complex/NN
variations/NNS
,/,
such/JJ
as/IN
SVs/NNS
,/,
CNVs/NNS
,/,
large/JJ
indels/VBZ
,/,
and/CC
transposons/NNS
./.
====================
-/:
Candidate/NN
gene/NN
prioritization/NN
./.
====================
Develop/IN
complex/NN
prioritization/NN
strategies/NNS
for/IN
large/JJ
pedigrees/NNS
,/,
combine/VBP
linkage/NN
analysis/NN
with/IN
association/NN
studies/NNS
,/,
and/CC
integrate/JJ
pathway/NN
analysis/NN
to/TO
eliminate/VB
false/VBP
positive/JJ
genes/NNS
./.
====================
-/:
Non-coding/JJ
variant/JJ
annotation/NN
./.
====================
Understand/CC
the/DT
functional/JJ
impact/NN
of/IN
non-coding/JJ
DNA/NN
elements/NNS
,/,
as/IN
the/DT
Encyclopedia/NN
of/IN
DNA/NN
Elements/NNS
(/(
ENCODE/NN
)/)
Project/JJ
intended/JJ
to/TO
do/VBP
,/,
to/TO
greatly/RB
broaden/JJ
our/PRP$
view/NN
of/IN
disease-causing/VBG
mutations/NNS
./.
====================
-/:
Cloud/NN
computing/VBG
./.
====================
High-throughput/JJ
sequencing/NN
projects/NNS
generate/VBP
large/JJ
amounts/NNS
of/IN
data/NNS
,/,
create/VBP
huge/JJ
computational/JJ
challenges/NNS
,/,
and/CC
require/VB
numerous/JJ
tools/NNS
and/CC
libraries/NNS
for/IN
comprehensive/JJ
data/NNS
analysis/NN
./.
====================
Develop/IN
cloud-based/VBN
computing/VBG
resources/VBZ
,/,
such/JJ
as/IN
the/DT
1000/CD
Genome/NN
Project/JJ
(/(
http/NN
:/:
//aws.amazon.com/1000genomes//JJ
)/)
,/,
to/TO
create/VB
a/DT
more/RBR
efficient/JJ
way/NN
of/IN
managing/VBG
,/,
processing/NN
,/,
and/CC
sharing/VBG
data/NNS
./.
====================
High-throughput/JJ
sequencing/NN
will/MD
continue/VB
to/TO
transform/VB
biomedical/JJ
sciences/VBZ
in/IN
almost/RB
every/RB
aspect/NN
[/(
51/CD
]/)
and/CC
provide/VBP
new/JJ
insights/NNS
for/IN
our/PRP$
understanding/NN
of/IN
human/JJ
diseases/NNS
./.
====================
For/IN
example/NN
,/,
three/CD
groups/NNS
recently/RB
reported/VBN
discoveries/VBZ
of/IN
several/JJ
new/JJ
autism/NN
genes/NNS
and/CC
suggested/VBD
a/DT
much/RB
more/RBR
complex/NN
disease/NN
mechanism/NN
,/,
based/VBN
on/IN
large-scale/JJ
sequencing/NN
data/NNS
of/IN
nearly/RB
600/CD
trios/NNS
and/CC
935/CD
additional/JJ
cases/NNS
[/(
52-54/CD
]/)
./.
====================
Along/IN
with/IN
the/DT
revolutionary/JJ
discoveries/NNS
based/VBN
on/IN
NGS/NN
data/NNS
,/,
new/JJ
tools/NNS
and/CC
techniques/NNS
will/MD
be/VB
developed/VBN
to/TO
facilitate/VB
fast/JJ
and/CC
accurate/VBP
analysis/NN
./.
====================
Example/NN
workflow/NN
for/IN
disease/NN
gene/NN
identification/NN
using/VBG
next-generation/JJ
sequencing/NN
data/NNS
./.
====================
SAM/NN
,/,
sequence/NN
alignment/map/VBP
;/:
BAM/NN
,/,
binary/NN
format/IN
;/:
SNP/NN
,/,
single/JJ
nucleotide/NN
polymorphism/NN
;/:
VCF/NN
,/,
variant/JJ
call/JJ
format/IN
./.
====================
